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Cardiac magnetic resonance imaging (CMR) has an important emerging role in the evaluation and management of patients who
present with symptoms concerning for acute coronary syndrome (ACS). This paper discusses the role of CMR in the emergency
department setting, where CMR can aid in the early and accurate diagnosis of non-ST elevation ACS in low and intermediate risk
patients. For those with conﬁrmed myocardial infarction (MI), CMR provides comprehensive prognostic information and can
readily diagnose structural complications related to MI. Furthermore, the pattern of late gadolinium enhancement (LGE) seen on
CMR can help determine the etiology of cardiac injury in the subset of patients presenting with ACS who do not have obstructive
coronary artery disease by angiography.
1.Introduction
Currently, more than a third of the 5.5 million people
who present to the emergency department (ED) annually in
the United States with a chief complaint of chest pain are
admitted to the hospital, while only about a third of those
admittedareeventuallygiventhediagnosisofacutecoronary
syndrome (ACS) [1, 2]. Thus, the emergency department
physician is confronted on a daily basis with patients who
have symptoms worrisome for possible ACS. Available tools
in the ED, which include a detailed medical history, physical
exam, ECG, and serum cardiac biomarkers, have limitations
for accurately and rapidly diagnosing ACS. Cardiac troponin
I/T are quite sensitive for detecting myocardial injury, but
often do not become elevated until hours after an infarction
has occurred and may not be elevated in ACS without
myocardial infarction. Triaging of these patients may be
straightforward for high-risk patients, especially those with
positive serum biomarkers (troponin I or T or myocardial
fraction of creatine kinase) or with evidence of myocardial
infarction (MI) on an electrocardiogram (ECG). However,
for low- and intermediate-risk patients without immediate
evidence of ischemia or MI on presentation, the decision
of whether to admit can often be challenging. Furthermore,
there is evidence that a small, but clinically signiﬁcant
number of patients are discharged from the ED with a
missed diagnosis of ACS, including MI [3]. Missing the
diagnosis of ACS and inappropriately discharging patients
can result in adverse patient outcomes and is the leading
cause of malpractice lawsuits and verdicts for physicians in
the emergency room [4]. Because of the high prevalence
and mortality associated with ACS, long observation times
or admission to the hospital is often required. Even after
patients have “ruled out” for MI, further functional or2 Cardiology Research and Practice
anatomic testing is frequently performed for risk stratiﬁ-
cation. An ideal test for ACS in the ED would be able to
quickly, accurately, and noninvasively triage patients with
ACS symptoms shortly after arrival to the ED. Cardiac
magnetic resonance imaging (CMR) is proving to be a
powerful tool for the early identiﬁcation or exclusion of ACS
as the cause of a patient’s chest pain syndrome. Patients with
evidence of MI on presentation to the ED often undergo an
early invasive strategy consisting of cardiac catheterization
with potential percutaneous coronary intervention (PCI).
In this setting, CMR, performed after the intervention, has
been shown to provide valuable prognostic information.
Patients at low risk for ACS following CMR examination can
potentially be discharged, thus reducing cost from unnec-
essary hospital admission. Additionally, for the challenging
subset of patients with evidence of MI on presentation,
but who have normal coronary arteries at catheterization,
CMR is uniquely able to identify the correct etiology in the
majority of cases. This paper will discuss the role of CMR
in the early evaluation of patients presenting to the ED with
symptoms concerning for ACS, the role of CMR after MI,
and the role of CMR for assessing patients presenting with
ACS who are found to have nonobstructive CAD by cardiac
catheterization.
2. CMR Techniquesfor EvaluatingACS
CMR is capable of performing a rapid and comprehensive
evaluation of cardiac anatomy, function, and myocardial
perfusion at rest and/or during stress. CMR can accurately
identify the presence of infarction, myocardial edema,
microvascular obstruction, and intramyocardial hemor-
rhage. The sequence of a typical CMR exam for ACS usually
begins with anatomic images of the chest, which can often
provide clues about other pathologies that may be causing
the patient’s chest pain. Cine steady-state free precession
imaging provides an assessment of myocardial and valvular
function and enables accurate assessment of left ventricular
ejection fraction (LVEF) and ventricular volumes. CMR
can assess myocardial edema and inﬂammation using T2-
weighted imaging due to the increased water content of the
myocardium. Edematous tissues with higher water content
have longer T2 relaxation times, leading to a brighter signal
on T2-weighted images. First-pass myocardial perfusion is
assessed using saturation-recovery gradient echo techniques
during intravenous injection of gadolinium contrast agents.
This can be performed during pharmacologic stress using
adenosine or dobutamine infusion providing an assessment
of myocardial ischemia. Myocardial scar is assessed by late
gadolinium-enhanced (LGE) imaging, the pattern of which
canhelpdiﬀerentiateinfarctionfromnonischemicprocesses.
Regions with myocardial scar have a higher concentration
of contrast agent and, thus, appear bright in these images.
Conversely, areas of microvascular obstruction, thrombus,
and myocardial hemorrhage appear dark on LGE imaging.
A complete CMR protocol can be performed in less than 45
minutes providing a rapid comprehensive assessment of the
heart.
3.DecidingWhether toAdmit
CMR has been shown to improve both the diagnostic
accuracy and time to diagnosis of ACS in the emergency
department setting. This was demonstrated in a study of
161 patients presenting to the ED within 12 hours of onset
of symptoms concerning for ACS, but without ST elevation
on ECG [5]. The CMR exam in this study included cine
MRI for LV function, resting ﬁrst-pass perfusion, and LGE.
Total CMR time was 38 minutes, and patients were gone
from the ED for less than 1 hour. The sensitivity and
speciﬁcity for diagnosis of ACS by CMR was 84% and
85%, respectively, and added independent diagnostic value
to clinical parameters [5]. The main limitation of CMR in
this study was its inability to diﬀerentiate acute from chronic
MI, a problem which was addressed in a subsequent study
by Cury et al., who added T2- w e i g h t e di m a g i n ga n dL Vw a l l
thickness quantiﬁcation to distinguish acute events [6]. T2-
weighted imaging enables visualization of edema associated
with acute, but not chronic, myocardial infarction [7]. In
this study, 62 patients with chest pain, normal ECG, and
negative initial cardiac biomarkers, who were being admitted
to the hospital to rule out MI, received CMR with an average
scan time of 32 minutes. CMR with T2-weighted imaging
accurately identiﬁed all acute MI cases, often before cardiac
biomarkers became elevated. Compared with conventional
CMR, the addition of T2-weighted edema imaging and wall
thickness quantiﬁcation increased speciﬁcity from 84% to
96%, positive predictive value from 55% to 85%, and overall
accuracy from 84% to 93%; respectively, while sensitivity
remained unchanged at 85% [6].
4. CMR without InitialEvidence of MI
A large proportion of low- and intermediate-risk patients
presenting to the ED with symptoms concerning for ACS
without evidence of MI undergo additional functional or
anatomic imaging on either an inpatient or outpatient basis.
CMR has been shown to compare favorably to other non-
invasive cardiac imaging modalities for diagnosing ischemia.
In a study by Nagel et al., 208 patients with suspected CAD
underwent both dobutamine stress echo and dobutamine
stress CMR prior to cardiac catheterization [8]. With CMR,
sensitivity and speciﬁcity for detecting a 50% coronary
stenosis was increased from 74.3% to 86.2% and from 69.8%
to85.7%,respectively,comparedwithechocardiography.Ina
study of 163 patients with poor acoustic windows preventing
adequate imaging by dobutamine stress echo, Hundley et al.
successfully performed dobutamine stress MRI in 153 of the
patients [9]. The sensitivity and speciﬁcity for detecting a
50% coronary stenosis were 83% and 83%, respectively, in
the 41 patients undergoing coronary angiography within 6
months of their stress test. In the 103 patients with negative
stress tests, the event free survival at a median followup
of 228 days was 97% [9]. A meta-analysis of dobutamine
stress CMR including 14 studies (754 patients) with a
high prevalence of coronary disease (prevalence: 70.5%)
demonstrated a sensitivity of 83% and speciﬁcity of 86%
[10]. Adenosine stress cardiac MRI has also been shownCardiology Research and Practice 3
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Figure 1: CMR with pharmacologic stress. An example of an
adenosine stress CMR in a diabetic patient presenting with new
onset chest pain. Resting ﬁrst-pass perfusion images (top panels)
areshownabovethecorrespondingstressperfusionimages(bottom
panels) in the basal, midventricular, and apical short-axis views.
There are inferior and anterior resting perfusion defects in the basal
short-axisslice,butwithstressthispatientdevelopsasevereinferior
perfusion defect extending to the lateral wall and septum in the
midventricleandapex.Oncardiaccatheterization(notshown),this
patient had multivessel CAD.
to be both sensitive and speciﬁc for detection of CAD.
A meta-analysis including 1658 patients with intermediate
likelihood of disease undergoing adenosine stress perfusion
MRI demonstrated a sensitivity of 90% and speciﬁcity of
81%. The negative likelihood ratio of adenosine stress in this
study was 0.14 [11]. A recent multicenter trial of 234 patients
who were studied with both single photon emission com-
puted tomography (SPECT) and CMR perfusion imaging
demonstrated superior diagnostic utility for CMR perfusion
at the ideal contrast dose as compared to SPECT [12]. In
lower-risk populations presenting to the ED with chest pain,
negative ECG, and negative serial cardiac biomarkers, CMR
was performed in two separate studies evaluating a total of
192 patients who received adenosine stress and rest CMR, LV
function assessment, and LGE [13, 14]. None of the patients
with a normal CMR in either of these studies had any clinical
events at 9-month followup. This was corroborated in a
similar study of 135 low-risk patients presenting to the ED
with chest pain who received adenosine stress CMR [15].
At 1 year followup, no patients with a normal stress CMR
were found to have a signiﬁcant coronary stenosis or cardiac
event, yielding a sensitivity and speciﬁcity of 100% and 93%,
respectively. Figure 1 shows an example of an adenosine
stress CMR study in a diabetic patient presenting with new
onset chest pain. Stress imaging demonstrates a large area of
ischemia. This patient was found to have multivessel CAD.
The costeﬀectiveness of using stress CMR to evaluate
intermediate- and high-risk patients in the ED setting was
evaluated in a study of 110 patients with chest pain, negative
ECG, and negative initial biomarkers, being admitted to
the hospital to rule out MI [16]. These patients were
randomized to obtain adenosine stress CMR while in the ED
or usual inpatient care. All health care costs relating to their
hospitalization and cardiac care over 30 days were included.
There was no diﬀerence in 30-day outcomes between the
groups. A diagnostic protocol which included stress CMR
was found to reduce inpatient admissions and produced
a cost savings of over 20% in this study [16]. Further
cost-eﬀectiveness studies are still needed to address the
ﬁnancial implications of utilizing stress CMR in lower-risk
populations.
5. CMR following MyocardialInfarction
For those patients who present early after symptom onset
with ST elevation MI (STEMI) or without ST elevation, but
with elevated cardiac biomarkers (non ST elevation MI, or
NSTEMI), an early invasive strategy with cardiac catheteri-
zation is generally recommended [17]. In these situations, it
is usually not helpful to perform noninvasive cardiac testing
prior to catheterization, because such tests could delay
treatment and would not be expected to aﬀect short-term
patient management. CMR can be performed safely in MI
patients, even immediately after percutaneous intervention
[18, 19], add important prognostic information, diagnose
post-MI complications, and aid in deciphering the etiology
of cardiac injury in patients who present with STEMI,
but who are found to have normal coronary arteries at
catheterization. Figure 2 shows images from a patient who
had a CMR study shortly after presenting with acute chest
pain. In this case, edema imaging enabled appropriate
determination of the LAD as the culprit vessel, even though
there was no LGE in this region. The LGE in the lateral wall
was from a prior myocardial infarction.
5.1. Prognosis. Left ventricular function has long been
known to predict outcomes after MI. Impaired LV systolic
function and an elevated LV end-systolic volume (ESV)
are both powerful independent predictors of increased
mortality [20–24]. CMR has become the gold standard
for accurate quantiﬁcation of left ventricular function and
volumes. In contemporary CMR studies of post-MI patients,
LVEF and LVESV are consistently predictive of outcomes;
however, multiple studies have shown that other CMR-based
parameters of infarction, such as infarct size, microvascular
obstruction (MO), and myocardial salvage are more pow-
erful predictors of outcomes than simple LV function or
volume assessments [25–27].
5.2. Infarct Size. CMR-based assessment of infarct size using
late gadolinium enhancement (LGE) is well validated and
has been shown to be highly predictive of cardiac events
at followup. Yokota et al. evaluated 86 patients with prior
MI by CMR and found that infarct size by LGE was a
better predictor of cardiac events than LVEF, LVESV or
LVEDV, at 20 month follow up [27]. Cheong et al. followed
a cohort of 857 patients with and without coronary artery
disease for a median of 4.4 years and demonstrated that
LGE, LVEF and heart failure symptoms were independent
predictors of mortality [28]. Interestingly, patients with LGE
and an ejection fraction more than 50% had the same
outcomes as those with an LVEF less than 50% without
LGE [28]. A study by Larose et al. investigated 103 acute ST
elevation MI (STEMI) patients by CMR within 12 hours of4 Cardiology Research and Practice
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Figure 2: Determing acute from chronic infarcts. This patient had a CMR shortly after presenting with acute-onset chest pain. T2-weighted
imaging(a)revealsabrightsignalinthemid-anteroseptumandapex,signifyingedema,amarkerofacutemyocardialinjury.Lategadolinium
enhanced (LGE) imaging (b) shows an infarct in the mid-inferolateral wall, but minimal enhancement in the anteroseptum or apex. This
patient had a severely stenosed mid-LAD as well as an occluded obtuse marginal branch of the circumﬂex coronary artery. CMR in this case
was able to determine the culprit vessel.
PCI, after which they received a 6-month CMR and were
followed for clinical events for an average of 2.4 years [29].
It was demonstrated that LGE measured immediately after
revascularization strongly and independently predicted 6-
month LVEF and long-term major cardiac events better than
LVEForclinicalparameters.Thiswascorroboratedinastudy
of 122 STEMI patients who received CMR after revascular-
ization and were followed for 2 years. Infarct size was again
a stronger indicator of worsened LV function and clinical
outcomes at followup than were baseline measurements of
LV systolic performance [30].
5.3. Microvascular Obstruction. Microvascular obstruction
(MO) refers to severe capillary and endothelial damage
induced by prolonged ischemia, which prevents blood ﬂow
into the infarcted core after reperfusion. The extent of MO
usually peaks between 2 hours to 2 days after reperfusion
occurs[31–33],afterwhichittendstobestableinsizeuntilat
least day 9 [34]. Thereafter areas of MO involute and regress
and are rarely seen on followup CMR beyond 1 to 2 months
after MI.
CMR has become the gold standard for assessment
of MO, due to its excellent spatial resolution and tissue
characterization ability. MO can be assessed by CMR using
two separate techniques. Early MO is visualized early after
contrast injection using ﬁrst-pass perfusion. Typical pro-
tocols using this method deﬁne MO as hypoenhancement
of the myocardium persisting longer than 1 to 2 minutes
after initial contrast injection. The second technique collects
late LGE images 10 to 15 minutes after contrast injection,
and MO appears as an area or areas of hypoenhance-
ment encompassed within a core of enhanced infarcted
myocardium, often extending from the subendocardium.
This latter method in the literature is sometimes termed
persistent or late MO. Both methods of MO assessment have
been validated, and there is not yet a clear consensus as to
which method should be the preferred technique. Early MO
has been shown to be predictive of long-term infarct size,
infarct transmurality, LV function, and LV remodeling and is
also a powerful independent long-term prognostic indicator
of hard cardiac events even after controlling for infarct size
[26, 35]; however, timing of the CMR examination after MI
is important when assessing MO using ﬁrst-pass perfusion.
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of long-term functional or clinical outcomes until the later
time points [34, 35]. Late MO has also been shown to lend
additional prognostic information beyond that of infarct size
or transmurality. In a study of 110MI patients, Hombach et
al. found that late MO independently portended an increase
in cardiac events at 8-month followup and gave additional
prognostic information compared to infarct size alone [36].
This was corroborated in a CMR study of 67 STEMI patients
followed for 14 months, in which late MO was a better
predictor of adverse cardiac events than infarct size or
baselineejectionfraction[37].Datacomparingearlyandlate
MO are sparse, but, in a study by Nijveldt et al., 63 acute MI
patients who received PCI and optimal medical management
were followed by CMR with assessment of early, mid-, and
late MO 4 to 7 days after MI and followup CMR at 4 months.
In this study, late MO was a better predictor of follow up
LV ejection fraction, LV end-diastolic volume, and LV end-
systolic volume than early MO [38].
5.4. Area at Risk/Myocardial Salvage. The region of ischemic
myocardium within the perfusion bed of an occluded
coronaryarteryisthe“areaatrisk”ofinfarctionandispoten-
tially salvageable with appropriate and timely intervention.Cardiology Research and Practice 5
Theareaatrisk,asmeasuredbyT2-weightedCMR,correlates
very well to the area at risk determined histologically with
ﬂuorescein staining [39]. Similarly, T2-weighted in vivo
CMR measurement of the area at risk 2 days following MI
showedexcellentcorrelationtotheareaatriskdeterminedby
ﬂuorescent microspheres at the time of coronary occlusion
[40].
Accurate assessment of both infarct size and the area
at risk allows noninvasive measurement of a potentially
clinically important parameter: the amount of myocardial
salvage. The myocardial salvage index (MSI) is a measure
of the myocardium that has been spared infarction, pre-
sumably due to a given procedure or treatment, and has
important prognostic signiﬁcance. CMR trials of STEMI
patients undergoing PCI have repeatedly shown that an
increase in the time from symptom onset to PCI leads
to a signiﬁcant incremental increase in infarct size and
microvascular obstruction, with a corresponding decrease in
myocardial salvage, while the extent of myocardial edema,
or area at risk, remains unchanged [25, 41]. A trial of 208
STEMI patients who underwent PCI within 12 hours of
symptom onset demonstrated that patients with an MSI
above the study median experienced signiﬁcantly fewer
death, reinfarction, or heart failure events at 6 months when
compared with those with an MSI below the median (2.9%
versus 22.1%, P<0.001) [25] .M S Iw a sf o u n dt ob eab e t t e r
predictor of outcome on multivariate regression than infarct
size, MO, LVEF, TIMI ﬂow-grade after PCI or ST segment
resolution. Because of the unique ability of T2-weighted
CMRtodetectmyocardialsalvageandpredictadverseevents,
it may become an extremely valuable surrogate measure of
outcome in studies of reperfusion therapy.
5.5. Right Ventricular Infarction. Another prognostic indica-
tor after MI is the presence of right ventricular (RV) infarc-
tion. RV infarction has been associated with an increased
risk of cardiogenic shock, atrioventricular conduction block,
and rupture of the interventricular septum [42]. In-hospital
mortality after RV infarction has been reported to be as high
as 50% but, among survivors to hospital discharge, does not
seem to predict long-term outcomes [43]. CMR has been
demonstrated to be much more sensitive for detecting small
or medium RV infarcts than physical exam, ECG with right-
sided leads, or echocardiography [44, 45]. RV infarction, as
seen by LGE of the RV after MI, was shown to be predictive
of RV dilation at 6-month followup [46]. Furthermore, a
recent CMR study of 50 MI patients undergoing successful
PCI and followed for an average of 32 months reported
RV involvement by LGE in 47% and 65% of inferior and
anterior MIs; respectively, and found that RV infarction was
a signiﬁcant independent predictor of cardiac events (odds
ratio: 15.8; 95% CI: 4–63), even after controlling for LV
infarct size and location [45].
5.6. Postinfarct Complications. Due to CMR’s unique tissue
characterization abilities and spatial resolution, it is an
ideal imaging modality for assessing complications arising
after MI. CMR is widely considered the gold standard for
analyzing both regional and global ventricular function after
MI [47] and can comprehensively evaluate both systolic
and diastolic function [48]. CMR can also readily detect
ventricular wall pathology such as ventricular septal defects
or free-wall aneurysms and can diﬀerentiate aneurysms
from pseudoaneurysms, with its accompanying treatment
implications. Visualization of LGE within the papillary
muscles is indicative of infarction and has been reported
in post-MI CMR studies to occur in 26 to 53% of
patients [36, 49]. In a study of 60 patients with old MI,
bilateral papillary muscle infarction was seen by LGE in
17% of cases and was associated with a higher incidence
of severe mitral regurgitation and LV remodeling than in
those with unilateral or no papillary muscle infarction
[49]. Inﬂammatory pericarditis is visualized by LGE of the
pericardium with high sensitivity and speciﬁcity after MI
[50] and has been reported to occur in as many as 40%
of STEMI patients [36]. CMR can also be beneﬁcial in
the evaluation of intraventricular thrombi. The presence of
intraventricular thrombi has been reported in 7 to 29% of
patients with decreased ejection fraction, depending on the
population studied [51, 52], and is associated with a higher
risk of thromboembolic events, including stroke [51, 53].
The most prominent risk factors for the development of
LV thrombus include anterior infarction, infarct size, LV
aneurysm, and decreased ejection fraction [52, 54]. A CMR
protocol which includes LGE assessment has been shown to
more accurately diagnose thrombi within the ventricle than
transthoracic echocardiography (TTE) or transesophageal
echocardiography (TEE). In a multimodality imaging, study
of 361 patients with ischemic cardiomyopathy undergoing
cardiac surgery, the presence of LV thrombus by CMR, TTE,
andTEEwerecomparedtopathologyandwerefoundtohave
sensitivities and speciﬁcities of 88% and 99% for CMR, 23%
and 96% for TTE, and 40% and 96% for TEE, respectively
[51]. While contrast echocardiography nearly doubles the
sensitivity of noncontrast echo, mural, and small apical LV
thrombi are still frequently missed [55]. Recently, the use of
prolonged inversion times (600 ms) during LGE imaging has
been shown to increase the sensitivity of LGE for detecting
thrombus even further [52]. Figure 3 shows images from a
patient who presented late after an STEMI demonstrating a
large area of LGE and the presence of an apical thrombus.
6.MyocardialInjurywith
Normal Coronary Arteries
An estimated 9–14% of patients who are diagnosed with
STEMI will be found to have normal coronary arteries at
cardiac catheterization [56]. These patients are at similar risk
for mortality as those with CAD and often have an under-
lying pathology which can be diﬃcult to diagnose. CMR
is uniquely able to shed light on the underlying pathology
in the majority of patients with MI with normal coronary
arteries. The pattern of late gadolinium enhancement and
myocardial edema in these patients is often helpful in diﬀer-
entiating the cause of injury. Ischemic necrosis begins in the
subendocardium before extending to the epicardium; thus,6 Cardiology Research and Practice
(a) (b) (c) (d)
Figure 3: CMR imaging after acute MI. The tissue characterization abilities of CMR are demonstrated in these frames, all of which were
takenfromapatientwhopresentedlateafteranSTelevationMI.A4-chambercinesteady-statefreeprecession(SSFP)imageisshownin(a).
Prior to contrast, it is diﬃcult to discern whether there is thrombus in the apex. A postcontrast 4-chamber SSFP image (b) provides greater
contrast between the slightly enhancing myocardium and nonenhancing thrombus at the apex. This diﬀerence is even more clear with late
gadolinium-enhanced (LGE) imaging (c)-(d), which clearly demonstrates the black thrombus at the apex adjacent to the transmural apical
infarct seen in white. An apical short axis view (d) reveals an extensive infarct with an area of microvascular obstruction visualized in the
septum (arrow).
(a) (b)
(c) (d)
Figure 4: Myocardial infarction with normal coronary arteries. Images from a patient presenting with chest pain, elevated troponin but
normal coronary arteries. Cine-SSFP images at (a) diastole and (b) systole demonstrate a wall motion abnormality in the inferoseptum and
anterolateral walls. T2 weighted imaging (c) shows focal areas of edema in these regions. (d) LGE imaging demonstrates epicardial-delayed
enhancement. These ﬁndings are consistent with the diagnosis of myocarditis.Cardiology Research and Practice 7
sparing of the subendocardium in infarction is extremely
rare.Conversely,subendocardialsparingiscommoninmany
nonischemic cardiomyopathies. Although myocarditis can
present with varied LGE patterns, the classical appearance
consistsofamidwallorepicardialstripeofenhancement,the
location of which can be indicative of the viral etiology [57,
58]. Figure 4 shows CMR images from a patient presenting
with acute chest pain and a troponin elevation. Edema imag-
ing indicated acute inﬂammation in the inferoseptum and
anterolateral walls. LGE imaging shows epicardial scarring
associated with myocarditis. Tako-Tsubo’s (stress-induced)
cardiomyopathy, on the other hand, does not lead to scar
formationorLGE.Inastudyof1345patientswithdiagnosed
STEMI, 127 (9.5%) were found on angiography to have no
coronary artery disease [59]. CMR in these patients had a
75% diagnostic yield and diﬀerentiated 31% as myocarditis,
31% as Tako-Tsubo cardiomyopathy, and 29% as STEMI
without an angiographic lesion. This was corroborated in
study of 60 patients with troponin-positive chest pain, but
unobstructed coronary arteries, which also found that CMR
was able to provide a speciﬁc diagnosis in the majority
of patients, diagnosing 50% of these cases as myocarditis
and 11.6% as MI [60]. Myocardial edema, as seen with T2-
weighted CMR, can help diﬀerentiate acute from chronic
episodes of both ischemic and nonischemic events, and
has been found to be present in acute episodes of Tako-
Tsubo’s cardiomyopathy [61, 62], myocarditis [63], cardiac
sarcoid [64], pulmonary hypertension [65], acute transplant
rejection [66], and recent cardiac surgery.
7. ComparativeEffectivenessof CMRinACS
In the current era of cost awareness, there is an appropriate
focus on the ability of an imaging modality to improve
cost and real patient outcomes when compared with other
available diagnostic strategies. As already discussed, there
is a relatively large body of evidence demonstrating that
CMR oﬀers excellent diagnostic and prognostic data in ACS
patients and that it compares favourably to other imaging
modalities. It has also been found to be cost eﬀective in a
selected population of patients presenting to the ED with
suspectedACS[16].CMRcanplayakeyroleinappropriately
determining which patients with chest pain need to be
admitted for further management and which patients can
be safely discharged to home; this could reduce costs related
to unnecessary inpatient care. There is still a great need,
however, for further studies to clarify CMR’s ability to
directly change management, improve meaningful patient
outcomes, and reduce overall costs of ACS care in the ED.
8. Conclusions
CMR has emerged as a robust diagnostic imaging modality
capable of providing a comprehensive cardiac evaluation
for patients with ACS. CMR is widely regarded as the
reference standard for assessment of cardiac structure and
function. In patients with acute myocardial infarction, CMR
provides powerful diagnostic and prognostic information,
allowing evaluation of cardiac function, infarct size and
location, infarct complications, the extent of edema or area
at risk, the amount of myocardial salvage, and the status of
the microvasculature—all in a single scan. CMR has been
shown to be safe, even immediately after PCI in STEMI
patients [18, 19], and a comprehensive exam can typically
be performed in less than 45 minutes without exposing
the patient to radiation. For those with normal coronary
arteries in the setting of MI, CMR provides clues to the
underlying diagnosis in the majority of cases. For patients
presenting to the emergency department with symptoms
and risk factors concerning for ACS, but without evidence
of MI, a comprehensive CMR study can also include stress
perfusion imaging, allowing accurate functional assessment
of the coronary circulation, which has been validated in both
low and high risk study populations. T2-weighted imaging
of edema and late gadolinium enhancement have the ability
to detect infarction and severe ischemia early in the course
of MI, even before cardiac biomarkers become elevated, and
can diﬀerentiate acute from chronic infarction. Importantly,
adding CMR to the emergency physician’s tool belt has
been shown to improve diagnostic accuracy compared to
current standards of care and to be cost eﬀective in certain
populations. Taken together, CMR provides a wealth of
meaningful diagnostic and prognostic data for a wide range
of patient populations with suspected or conﬁrmed acute
coronary syndrome.
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